These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37375183)

  • 21. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
    Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Biological Evaluation of Novel Thioether Pleuromutilin Derivatives.
    Mu S; Liu H; Zhang L; Wang X; Xue F; Zhang Y
    Biol Pharm Bull; 2017; 40(8):1165-1173. PubMed ID: 28768998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hit-to-Lead Identification and Validation of a Triaromatic Pleuromutilin Antibiotic Candidate.
    Heidtmann CV; Fejer AR; Stærk K; Pedersen M; Asmussen MG; Hertz FB; Prabhala BK; Frimodt-Møller N; Klitgaard JK; Andersen TE; Nielsen CU; Nielsen P
    J Med Chem; 2024 Mar; 67(5):3692-3710. PubMed ID: 38385364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
    Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia.
    Watkins RR; File TM
    Clin Infect Dis; 2020 Dec; 71(10):2757-2762. PubMed ID: 32221520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
    Huang SY; Wang X; Shen DY; Chen F; Zhang GY; Zhang Z; Li K; Jin Z; Du D; Tang YZ
    Bioorg Med Chem; 2021 May; 38():116138. PubMed ID: 33857737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction: lefamulin and pharmacokinetic/pharmacodynamic rationale to support the dose selection of lefamulin.
    Rodvold KA
    J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii2-iii4. PubMed ID: 30949709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
    Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
    Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular networking assisted discovery and combinatorial biosynthesis of new antimicrobial pleuromutilins.
    Guo C; Dai H; Zhang M; Liao H; Zhang R; Chen B; Han J; Liu H
    Eur J Med Chem; 2022 Dec; 243():114713. PubMed ID: 36087386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial Activity and Structure-Activity Relationship of a Series of Newly Synthesized Pleuromutilin Derivatives.
    Li YG; Wang JX; Zhang GN; Zhu M; You XF; Hu XX; Zhang F; Wang YC
    Chem Biodivers; 2019 Feb; 16(2):e1800560. PubMed ID: 30467968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
    Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
    Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
    Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R
    Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel pleuromutilin derivatives targeting the 50S ribosomal subunit for antibacterial ability.
    Liu Q; Zhang H; Yi Y; Wang P; Pu W; Wang S; Shang R
    Eur J Med Chem; 2023 Dec; 262():115882. PubMed ID: 37879170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
    Bioorg Med Chem Lett; 2009 Jan; 19(1):175-9. PubMed ID: 19022668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis and biological evaluation of novel pleuromutilin derivatives with nitrogen-containing heterocycles as antibacterial agents].
    Wang XY; Chen M; Wang D; Chen XD; Ling Y; Wang XL; Wang H
    Yao Xue Xue Bao; 2015 Oct; 50(10):1297-304. PubMed ID: 26837177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.
    Li YG; Wang JX; Zhang GN; Zhu M; You XF; Wang YC; Zhang F
    Bioorg Med Chem Lett; 2020 Apr; 30(7):126969. PubMed ID: 32014384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and antibacterial activity evaluation of pleuromutilin derivatives according to twin drug theory.
    Liu HX; Cui G; Ma DL; Zhang Y; Xue FQ
    J Asian Nat Prod Res; 2022 Apr; 24(4):371-387. PubMed ID: 33985386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
    Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pleuromutilin antibiotics: a new class for human use.
    Novak R; Shlaes DM
    Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.